首页 > 最新文献

CardioVascular and Interventional Radiology最新文献

英文 中文
Impact of the 2025 CIRSE Classification on Complication Grading: Insights from a Comparative Analysis. 2025年CIRSE分级对并发症分级的影响:来自比较分析的见解。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-29 DOI: 10.1007/s00270-026-04355-0
Davide Castiglione, Gioele Vitaliti, Francesco Tiralongo, Antonio Basile
{"title":"Impact of the 2025 CIRSE Classification on Complication Grading: Insights from a Comparative Analysis.","authors":"Davide Castiglione, Gioele Vitaliti, Francesco Tiralongo, Antonio Basile","doi":"10.1007/s00270-026-04355-0","DOIUrl":"https://doi.org/10.1007/s00270-026-04355-0","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embolisation of Type 2 Endoleaks Associated with Sac Expansion-Outcomes from a Single-Centre Cohort. 2型肺泡囊扩张相关的栓塞——来自单中心队列的结果
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-29 DOI: 10.1007/s00270-025-04272-8
Joo-Young Chun, Shyamal Patel, Seyed Ameli-Renani, Vyzantios Pavlidis, Robert Morgan

Purpose: To describe the outcomes of a patient cohort following transcatheter embolisation for type 2 endoleaks associated with sac expansion.

Materials and methods: A retrospective single-centre observational study was performed between September 2005 and June 2023. Technical success rates and long-term outcomes were evaluated including technical factors associated with endoleak recurrence and rupture. One hundred transcatheter embolisations were performed for type 2 endoleaks in 72 patients (64 male and 8 female).

Results: Technical success (cessation of flow in the endoleak on angiography) was achieved in 77/100 (77%) procedures. Clinical success (freedom from sac growth on surveillance) was achieved in 82% at 12 months, 70% at 24 months and 59% at 60 months. Persistent endoleaks were found in 27%, with 7% developing a new type 2 and 14% developing new type 1, 3 or 5 endoleaks. The rupture rate was 7%, including 2/7 persistent type 2 endoleaks, 4/7 new type 1 or 3 endoleaks and 1/7 type 5 endoleak. Embolisation was performed either via a transarterial route (74%) or via direct sac puncture (24%), the latter demonstrating a significant correlation with technical success (p=0.018).

Conclusions: This study confirms the importance of embolisation as the main treatment modality of type 2 endoleaks with freedom from sac growth achieved in 70% of patients at 24 months. However, this remains a complex entity with persistent sac growth, risking the development of type 1 or 3 endoleaks, which carry a risk of late sac rupture.

目的:描述经导管栓塞治疗伴有囊扩张的2型内漏的患者队列的结果。材料和方法:2005年9月至2023年6月进行回顾性单中心观察性研究。评估技术成功率和长期结果,包括与内漏复发和破裂相关的技术因素。72例(男64例,女8例)进行了100例经导管栓塞治疗2型内漏。结果:100例手术中有77例(77%)取得了技术上的成功(血管造影显示腔内血流停止)。12个月时临床成功率为82%,24个月时为70%,60个月时为59%。27%的患者存在持续性内漏,其中7%发展为新的2型内漏,14%发展为新的1型、3型或5型内漏。破裂率为7%,其中2/7为持续性2型,4/7为新的1或3型,1/7为5型。栓塞通过经动脉途径(74%)或直接囊穿刺(24%)进行,后者显示出与技术成功率显著相关(p=0.018)。结论:这项研究证实了栓塞作为2型内漏的主要治疗方式的重要性,70%的患者在24个月时实现了囊腔生长的自由。然而,这仍然是一个复杂的实体,持续的囊生长,有发展成1型或3型内漏的风险,这有后期囊破裂的风险。
{"title":"Embolisation of Type 2 Endoleaks Associated with Sac Expansion-Outcomes from a Single-Centre Cohort.","authors":"Joo-Young Chun, Shyamal Patel, Seyed Ameli-Renani, Vyzantios Pavlidis, Robert Morgan","doi":"10.1007/s00270-025-04272-8","DOIUrl":"https://doi.org/10.1007/s00270-025-04272-8","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the outcomes of a patient cohort following transcatheter embolisation for type 2 endoleaks associated with sac expansion.</p><p><strong>Materials and methods: </strong>A retrospective single-centre observational study was performed between September 2005 and June 2023. Technical success rates and long-term outcomes were evaluated including technical factors associated with endoleak recurrence and rupture. One hundred transcatheter embolisations were performed for type 2 endoleaks in 72 patients (64 male and 8 female).</p><p><strong>Results: </strong>Technical success (cessation of flow in the endoleak on angiography) was achieved in 77/100 (77%) procedures. Clinical success (freedom from sac growth on surveillance) was achieved in 82% at 12 months, 70% at 24 months and 59% at 60 months. Persistent endoleaks were found in 27%, with 7% developing a new type 2 and 14% developing new type 1, 3 or 5 endoleaks. The rupture rate was 7%, including 2/7 persistent type 2 endoleaks, 4/7 new type 1 or 3 endoleaks and 1/7 type 5 endoleak. Embolisation was performed either via a transarterial route (74%) or via direct sac puncture (24%), the latter demonstrating a significant correlation with technical success (p=0.018).</p><p><strong>Conclusions: </strong>This study confirms the importance of embolisation as the main treatment modality of type 2 endoleaks with freedom from sac growth achieved in 70% of patients at 24 months. However, this remains a complex entity with persistent sac growth, risking the development of type 1 or 3 endoleaks, which carry a risk of late sac rupture.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cryoneurolysis in Chronic Pain Management: Translating Expert Consensus into Real-world Interventional Practice. 慢性疼痛管理中的冷冻神经溶解:将专家共识转化为现实世界的介入实践。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-29 DOI: 10.1007/s00270-026-04350-5
Kin Fen Kevin Fung
{"title":"Cryoneurolysis in Chronic Pain Management: Translating Expert Consensus into Real-world Interventional Practice.","authors":"Kin Fen Kevin Fung","doi":"10.1007/s00270-026-04350-5","DOIUrl":"https://doi.org/10.1007/s00270-026-04350-5","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on Transfissural Route: A Safe Pathway for Medical Adhesive Localization of Challenging Pulmonary Nodules. 经裂路径:一种安全的医用粘接剂定位挑战性肺结节的途径。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-29 DOI: 10.1007/s00270-026-04346-1
Toshihiro Iguchi, Yusuke Matsui, Takao Hiraki
{"title":"Commentary on Transfissural Route: A Safe Pathway for Medical Adhesive Localization of Challenging Pulmonary Nodules.","authors":"Toshihiro Iguchi, Yusuke Matsui, Takao Hiraki","doi":"10.1007/s00270-026-04346-1","DOIUrl":"https://doi.org/10.1007/s00270-026-04346-1","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravascular Ultrasound Enhances Diagnostic Yield and Interventional Decision-Making in Upper Extremity and Thoracic Veno-Occlusive Disease. 血管内超声提高上肢和胸部静脉闭塞性疾病的诊断率和介入决策。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-29 DOI: 10.1007/s00270-026-04347-0
Cody R Criss, Jeffrey Forris Beecham Chick, Colvin Greenberg, Matthew Abad-Santos, Grace Laidlaw, Eric J Monroe, David Shin, Mina S Makary
{"title":"Intravascular Ultrasound Enhances Diagnostic Yield and Interventional Decision-Making in Upper Extremity and Thoracic Veno-Occlusive Disease.","authors":"Cody R Criss, Jeffrey Forris Beecham Chick, Colvin Greenberg, Matthew Abad-Santos, Grace Laidlaw, Eric J Monroe, David Shin, Mina S Makary","doi":"10.1007/s00270-026-04347-0","DOIUrl":"https://doi.org/10.1007/s00270-026-04347-0","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interest Trajectories of Emerging Embolization Procedures: A Google Trends and PubMed Analysis. 新兴栓塞手术的兴趣轨迹:b谷歌趋势和公共医学分析。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-29 DOI: 10.1007/s00270-026-04352-3
Francois H Cornelis, Ruben Geevarghese, Stephen B Solomon, Dimitrios Filippiadis
{"title":"Interest Trajectories of Emerging Embolization Procedures: A Google Trends and PubMed Analysis.","authors":"Francois H Cornelis, Ruben Geevarghese, Stephen B Solomon, Dimitrios Filippiadis","doi":"10.1007/s00270-026-04352-3","DOIUrl":"https://doi.org/10.1007/s00270-026-04352-3","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistent Lymphatic Ascites After Liver Transplantation: Identification of the Underlying Mechanism of Ascites Permits Successful Percutaneous Treatment. 肝移植后持续性淋巴性腹水:腹水潜在机制的确定允许成功的经皮治疗。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-23 DOI: 10.1007/s00270-025-04332-z
Alexey Gurevich, Priscilla Stecher, Peter L Abt, Maarouf A Hoteit, Gregory J Nadolski, Deborah Rabinowitz, Maxim Itkin

Purpose: Approximately 1-7% of patients develop persistent lymphatic ascites after liver transplantation. This study describes the diagnosis and treatment of lymphatic ascites in patients post liver transplantation, refractory to conservative therapy.

Materials and methods: A review of the prospectively collected database was conducted to identify patients who received interventions for persistent lymphatic ascites following liver transplantation. Patient demographics, baseline characteristics, imaging findings, procedural details, and follow-up information were gathered.

Results: Four adult patients after orthotopic liver transplantation with chylous ascites (CA) and 4 pediatric patients after split liver transplantation with hepatic lymphorrhea (HL) were included in this study. CA patients were characterized by elevated triglycerides (1010 mg/dL, 442-1769), and HL patients were characterized by low serum albumin ascites gradient (SAAG < 1.1) and low triglycerides. In 3/4 patients with CA, dynamic contrast MR lymphangiography and intranodal lymphangiography demonstrated obstruction of the central lymphatic system. The mesenteric lymphatics were then embolized with either n-BCA glue or lipiodol. One-fourth patients had stenosis of the portal vein anastomosis, which was balloon dilated using a transjugular approach. All 4 patients reached resolution of ascites at a median of 27 days. In 3/4 patients presenting with HL, liver lymphangiography demonstrated extravasation of the contrast. That was embolized with either glue or lipiodol. One-fourth patient demonstrated no extravasation but significant lymphangiectasia. In all patients, there was a resolution of ascites at a median of 14 days after intervention.

Conclusion: Three mechanisms of post-transplantation lymphatic ascites were identified: portal venous hypertension due to iatrogenic obstruction; obstruction of central lymphatics resulting in congestion of the mesenteric lymphatic system and mesenteric lymphatic leak; and liver lymphorrhea. Identification of the mechanism of ascites allowed for successful percutaneous treatment in all patients.

目的:约1-7%的患者在肝移植后出现持续性淋巴腹水。本研究描述肝移植术后淋巴性腹水的诊断和治疗,保守治疗难治性。材料和方法:对前瞻性收集的数据库进行回顾,以确定接受肝移植后持续性淋巴腹水干预的患者。收集了患者人口统计、基线特征、影像学发现、手术细节和随访信息。结果:本研究纳入4例成人原位肝移植术后乳糜性腹水(CA)患者和4例小儿肝移植术后肝淋巴漏(HL)患者。CA患者的特点是甘油三酯升高(1010 mg/dL, 442-1769), HL患者的特点是血清白蛋白腹水梯度低(SAAG)。结论:移植后淋巴腹水的机制有三种:医源性梗阻导致门静脉高压;中心淋巴管梗阻导致肠系膜淋巴系统充血和肠系膜淋巴渗漏;腹水机制的鉴定使所有患者的经皮治疗成功。
{"title":"Persistent Lymphatic Ascites After Liver Transplantation: Identification of the Underlying Mechanism of Ascites Permits Successful Percutaneous Treatment.","authors":"Alexey Gurevich, Priscilla Stecher, Peter L Abt, Maarouf A Hoteit, Gregory J Nadolski, Deborah Rabinowitz, Maxim Itkin","doi":"10.1007/s00270-025-04332-z","DOIUrl":"https://doi.org/10.1007/s00270-025-04332-z","url":null,"abstract":"<p><strong>Purpose: </strong>Approximately 1-7% of patients develop persistent lymphatic ascites after liver transplantation. This study describes the diagnosis and treatment of lymphatic ascites in patients post liver transplantation, refractory to conservative therapy.</p><p><strong>Materials and methods: </strong>A review of the prospectively collected database was conducted to identify patients who received interventions for persistent lymphatic ascites following liver transplantation. Patient demographics, baseline characteristics, imaging findings, procedural details, and follow-up information were gathered.</p><p><strong>Results: </strong>Four adult patients after orthotopic liver transplantation with chylous ascites (CA) and 4 pediatric patients after split liver transplantation with hepatic lymphorrhea (HL) were included in this study. CA patients were characterized by elevated triglycerides (1010 mg/dL, 442-1769), and HL patients were characterized by low serum albumin ascites gradient (SAAG < 1.1) and low triglycerides. In 3/4 patients with CA, dynamic contrast MR lymphangiography and intranodal lymphangiography demonstrated obstruction of the central lymphatic system. The mesenteric lymphatics were then embolized with either n-BCA glue or lipiodol. One-fourth patients had stenosis of the portal vein anastomosis, which was balloon dilated using a transjugular approach. All 4 patients reached resolution of ascites at a median of 27 days. In 3/4 patients presenting with HL, liver lymphangiography demonstrated extravasation of the contrast. That was embolized with either glue or lipiodol. One-fourth patient demonstrated no extravasation but significant lymphangiectasia. In all patients, there was a resolution of ascites at a median of 14 days after intervention.</p><p><strong>Conclusion: </strong>Three mechanisms of post-transplantation lymphatic ascites were identified: portal venous hypertension due to iatrogenic obstruction; obstruction of central lymphatics resulting in congestion of the mesenteric lymphatic system and mesenteric lymphatic leak; and liver lymphorrhea. Identification of the mechanism of ascites allowed for successful percutaneous treatment in all patients.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Women in Interventional Radiology in India: Findings from a Nationwide Study. 印度介入放射学中的妇女:一项全国性研究的结果。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-23 DOI: 10.1007/s00270-025-04333-y
Nilu M Dhoot, Uma Pankar, Geetika Sindhwani, Shakthi Parvathi, Surabhi Jajodia, Behnam Shaygi

Purpose: This study aims to characterize the practice of female interventional radiologists (IRs) from India and identify gender-related barriers. It provides insights and baseline data to guide initiatives advancing gender equity and diversity in the specialty.

Methods: A cross sectional study of female members of the Indian Society of Vascular and Interventional Radiology (ISVIR) was conducted between February and July 2025. Respondents provided demographic data and perspectives on leadership, work-life balance, gender bias, and career satisfaction. Descriptive analysis and logistic regression identified predictors of career outcomes.

Results: ISVIR registry listed 1,553 members, of whom 163 (10.5%) were women. Of the 95 eligible women, 86 completed the study (86/95, 90.5%). Most respondents (53/86, 61.6%) were in early career stages(0-5 years post-training). Dual practice in diagnostic radiology and IR was common (54/86, 62.8%). Leadership roles were limited (20/86, 23.3%), and 43% (37/86) perceived gender-related barriers. Mentorship was predominantly male (71/86, 82.6%). Gender inequities were reported in salary (22/86, 25.6%), procedural access (49/86, 57%), and patient perceptions (45/86,52.3%). About 55.8% (48/86) reported marital status negatively impacted their careers. Burnout was perceived by 75.6% (65/86) of participants. Early career participants were more likely to leave IR (p = 0.027; OR = 0.293; 95% CI: 0.099-0.870), while seniors reported gender-based discrimination (p = 0.024; OR = 2.625; 95% CI: 1.137-6.062). Despite these challenges, (74/86) 86% described IR as rewarding, and (77/86) 89.6% would choose IR again.

Conclusion: Women represent a minority of the IR workforce in India, with the majority being in training/early career. Mentorship, marital status, salary, procedural access, and patient perceptions were potential gender barriers.

目的:本研究旨在描述印度女性介入放射科医师(IRs)的执业特征,并确定与性别相关的障碍。它提供了见解和基线数据,以指导促进该专业性别平等和多样性的举措。方法:在2025年2月至7月期间,对印度血管与介入放射学会(ISVIR)的女性会员进行了横断面研究。受访者提供了人口统计数据和对领导力、工作与生活平衡、性别偏见和职业满意度的看法。描述性分析和逻辑回归确定了职业结果的预测因子。结果:ISVIR注册表列出1,553名成员,其中163名(10.5%)为女性。在95名符合条件的女性中,86名完成了研究(86/95,90.5%)。大多数受访者(53/86,61.6%)处于职业早期阶段(培训后0-5年)。诊断放射学和红外双重执业较为常见(54/ 86,62.8%)。领导角色有限(20/86,23.3%),43%(37/86)认为存在与性别有关的障碍。师友以男性为主(71/86,82.6%)。薪资(22/ 86,25.6%)、程序准入(49/ 86,57%)和患者感知(45/86,52.3%)方面存在性别不平等。约55.8%(48/86)的受访者表示,婚姻状况对他们的职业生涯产生了负面影响。75.6%(65/86)的参与者感到倦怠。早期职业参与者更有可能离开IR (p = 0.027; OR = 0.293; 95% CI: 0.099-0.870),而老年人报告了基于性别的歧视(p = 0.024; OR = 2.625; 95% CI: 1.137-6.062)。尽管存在这些挑战,(74/86)86%的人认为IR是有益的,(77/86)89.6%的人会再次选择IR。结论:在印度,女性在IR劳动力中只占少数,大多数是在培训/早期职业。导师、婚姻状况、工资、程序准入和患者认知是潜在的性别障碍。
{"title":"Women in Interventional Radiology in India: Findings from a Nationwide Study.","authors":"Nilu M Dhoot, Uma Pankar, Geetika Sindhwani, Shakthi Parvathi, Surabhi Jajodia, Behnam Shaygi","doi":"10.1007/s00270-025-04333-y","DOIUrl":"https://doi.org/10.1007/s00270-025-04333-y","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to characterize the practice of female interventional radiologists (IRs) from India and identify gender-related barriers. It provides insights and baseline data to guide initiatives advancing gender equity and diversity in the specialty.</p><p><strong>Methods: </strong>A cross sectional study of female members of the Indian Society of Vascular and Interventional Radiology (ISVIR) was conducted between February and July 2025. Respondents provided demographic data and perspectives on leadership, work-life balance, gender bias, and career satisfaction. Descriptive analysis and logistic regression identified predictors of career outcomes.</p><p><strong>Results: </strong>ISVIR registry listed 1,553 members, of whom 163 (10.5%) were women. Of the 95 eligible women, 86 completed the study (86/95, 90.5%). Most respondents (53/86, 61.6%) were in early career stages(0-5 years post-training). Dual practice in diagnostic radiology and IR was common (54/86, 62.8%). Leadership roles were limited (20/86, 23.3%), and 43% (37/86) perceived gender-related barriers. Mentorship was predominantly male (71/86, 82.6%). Gender inequities were reported in salary (22/86, 25.6%), procedural access (49/86, 57%), and patient perceptions (45/86,52.3%). About 55.8% (48/86) reported marital status negatively impacted their careers. Burnout was perceived by 75.6% (65/86) of participants. Early career participants were more likely to leave IR (p = 0.027; OR = 0.293; 95% CI: 0.099-0.870), while seniors reported gender-based discrimination (p = 0.024; OR = 2.625; 95% CI: 1.137-6.062). Despite these challenges, (74/86) 86% described IR as rewarding, and (77/86) 89.6% would choose IR again.</p><p><strong>Conclusion: </strong>Women represent a minority of the IR workforce in India, with the majority being in training/early career. Mentorship, marital status, salary, procedural access, and patient perceptions were potential gender barriers.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unexpected Biliary Migration of N-Butyl Cyanoacrylate During Tract Embolization after Portal Vein Embolization. 门静脉栓塞后的胆道栓塞中n -氰基丙烯酸丁酯的意外胆道迁移。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-23 DOI: 10.1007/s00270-026-04345-2
Hiroki Satomura, Daisuke Katayama, Yusuke Ono, Takayasu Yamamoto, Hiroki Higashihara, Noriyuki Tomiyama
{"title":"Unexpected Biliary Migration of N-Butyl Cyanoacrylate During Tract Embolization after Portal Vein Embolization.","authors":"Hiroki Satomura, Daisuke Katayama, Yusuke Ono, Takayasu Yamamoto, Hiroki Higashihara, Noriyuki Tomiyama","doi":"10.1007/s00270-026-04345-2","DOIUrl":"https://doi.org/10.1007/s00270-026-04345-2","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Two Distal Radial Hemostatic Devices for Radial Artery Patency Post-TACE: A Randomized Trial. 比较两种桡动脉远端止血装置用于桡动脉tace后开放:一项随机试验。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-23 DOI: 10.1007/s00270-025-04337-8
Cheng-Chun Lee, Jia-Min Wu, Fen-Ni Tsai, Pao-Chia Chiu, Yu-Chen Chen, Ya-Lan Liang, Jen-I Hwang, Kuan-Chun Hsueh

Purpose: To compare the patency outcomes and safety profile between the modified TR Band and the PreludeSYNC DISTAL (PSD) for hemostasis following distal transradial access (dTRA) for transarterial chemoembolization (TACE).

Methods: This prospective randomized trial enrolled 104 participants undergoing TACE via dTRA (143 procedures, all performed using a 4-Fr catheter. Participants achieved hemostasis with either the modified TR Band (n = 74) or PSD (n = 69). The primary endpoint was the incidence of radial artery occlusion (RAO) assessed by Doppler ultrasonography at 4 h, 24 h, and > 1 week. Outcome assessors were blinded. Secondary endpoints included hemostatic performance and complications.

Results: No complete RAO occurred in either group (0/143). Partial RAO (mural thrombus with preserved flow) peaked at 4 h (TR Band: 28.4% vs. PSD: 18.8%; risk difference 9.5%, 95% CI -4.3 to 23.3%, p = 0.181) and declined to 4.1% vs. 2.9% by final follow-up (p = 1.000), representing a spontaneous resolution rate of 85.3%. Generalized estimating equations showed no significant difference in overall incidence. The TR Band group had a numerically higher rate of delayed hemostasis (> 4 h) compared with PSD (5.4% vs. 0.0%, p = 0.121). Complication rates (hematoma, pseudoaneurysm) did not differ significantly.

Conclusion: The modified TR Band and PSD demonstrated comparable rates of partial radial artery occlusion and access-site complications following dTRA for TACE.

目的:比较改良的TR带和PreludeSYNC远端(PSD)在经动脉化疗栓塞(TACE)的远端经桡动脉通路(dTRA)后止血的通畅结果和安全性。方法:这项前瞻性随机试验招募了104名通过dTRA进行TACE(143次手术)的参与者,所有患者均使用4-Fr导管。参与者使用改良的TR带(n = 74)或PSD (n = 69)实现止血。主要终点是桡动脉闭塞(RAO)的发生率,在4小时,24小时和bbb10 1周通过多普勒超声评估。结果评估者采用盲法。次要终点包括止血效果和并发症。结果:两组均未发生完全RAO(0/143)。部分RAO(保留血流的附壁血栓)在4小时达到峰值(TR波段:28.4% vs. PSD: 18.8%;风险差9.5%,95% CI -4.3 ~ 23.3%, p = 0.181),最终随访时下降到4.1% vs. 2.9% (p = 1.000),自发消退率为85.3%。广义估计方程显示总体发病率无显著差异。与PSD组相比,TR带组延迟止血率(bbb40 h)数值较高(5.4% vs 0.0%, p = 0.121)。并发症发生率(血肿、假性动脉瘤)无显著差异。结论:改良的TR带和PSD在TACE dTRA术后桡动脉部分闭塞和通路并发症发生率相当。
{"title":"Comparing Two Distal Radial Hemostatic Devices for Radial Artery Patency Post-TACE: A Randomized Trial.","authors":"Cheng-Chun Lee, Jia-Min Wu, Fen-Ni Tsai, Pao-Chia Chiu, Yu-Chen Chen, Ya-Lan Liang, Jen-I Hwang, Kuan-Chun Hsueh","doi":"10.1007/s00270-025-04337-8","DOIUrl":"https://doi.org/10.1007/s00270-025-04337-8","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the patency outcomes and safety profile between the modified TR Band and the PreludeSYNC DISTAL (PSD) for hemostasis following distal transradial access (dTRA) for transarterial chemoembolization (TACE).</p><p><strong>Methods: </strong>This prospective randomized trial enrolled 104 participants undergoing TACE via dTRA (143 procedures, all performed using a 4-Fr catheter. Participants achieved hemostasis with either the modified TR Band (n = 74) or PSD (n = 69). The primary endpoint was the incidence of radial artery occlusion (RAO) assessed by Doppler ultrasonography at 4 h, 24 h, and > 1 week. Outcome assessors were blinded. Secondary endpoints included hemostatic performance and complications.</p><p><strong>Results: </strong>No complete RAO occurred in either group (0/143). Partial RAO (mural thrombus with preserved flow) peaked at 4 h (TR Band: 28.4% vs. PSD: 18.8%; risk difference 9.5%, 95% CI -4.3 to 23.3%, p = 0.181) and declined to 4.1% vs. 2.9% by final follow-up (p = 1.000), representing a spontaneous resolution rate of 85.3%. Generalized estimating equations showed no significant difference in overall incidence. The TR Band group had a numerically higher rate of delayed hemostasis (> 4 h) compared with PSD (5.4% vs. 0.0%, p = 0.121). Complication rates (hematoma, pseudoaneurysm) did not differ significantly.</p><p><strong>Conclusion: </strong>The modified TR Band and PSD demonstrated comparable rates of partial radial artery occlusion and access-site complications following dTRA for TACE.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
CardioVascular and Interventional Radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1